R. Walgren
发表
R. Walgren,
C. Slapak,
2014
.
Rakesh Nagarajan,
Elaine R Mardis,
Jack Baty,
2008,
Blood.
S. Culine,
J. Hainsworth,
R. Huddart,
2017,
The Lancet.
R. Herbst,
D. Ferry,
R. Walgren,
2018,
The oncologist.
T. Powles,
C. Sternberg,
D. Petrylak,
2022,
British journal of clinical pharmacology.
R. Walgren,
A. Zimmermann,
Ling Gao,
2022,
Cancer Chemotherapy and Pharmacology.
D. Timm,
R. Walgren,
P. Ebert,
2018,
Oncotarget.
R. Walgren,
T. Walle,
U. Walle,
1999,
Research communications in molecular pathology and pharmacology.
R. Walgren,
A. Vogel,
J. Valle,
2016
.
R. Walgren,
A. Zimmermann,
Ling Gao,
2022,
Cancer Chemotherapy and Pharmacology.
E. Van Cutsem,
R. Walgren,
Li‐Tzong Chen,
2020
.
R. Walgren,
A. Zimmermann,
Ling Gao,
2020
.
A. Verma,
G. Martinelli,
R. Walgren,
2018,
Leukemia research.
R. Walgren,
J. Pagel,
A. Mato,
2022,
Clinical lymphoma, myeloma & leukemia.
R. Vij,
P. Westervelt,
J. Dipersio,
2009,
American journal of hematology.
M. Kohli,
D. Petrylak,
R. Walgren,
2015
.
R. Walgren,
Yongmei Chen,
H. Konig,
2022,
Advances in hematology.
J. Prchal,
R. Walgren,
2012
.
R. Walgren,
T. Walle,
R. Kinne,
2000,
The Journal of pharmacology and experimental therapeutics.
R. Walgren,
T. Walle,
G. Lindenmayer,
2000,
The Journal of pharmacology and experimental therapeutics.
A. Skol,
R. Larson,
M. L. Le Beau,
2009,
Blood.
H. McLeod,
R. Walgren,
2005,
Pharmacogenomics.
E. Plimack,
R. Walgren,
R. Cohen,
2019,
The oncologist.
R. Walgren,
J. Manro,
J. Wijsman,
2013,
Clinical Cancer Research.
R. Walgren,
J. Manro,
J. Wijsman,
2013
.
R. Walgren,
J. Manro,
J. Wijsman,
2013
.
M. Walter,
T. Graubert,
R. Walgren,
2009,
PloS one.
J. Graff,
R. Walgren,
C. Shih,
2012,
Investigational New Drugs.
S. Madhusudan,
R. Walgren,
R. Geva,
2018,
Journal of cachexia, sarcopenia and muscle.
R. Wilson,
C. Bloomfield,
M. McLellan,
2013
.
H. McLeod,
R. Walgren,
Melissa A Meucci,
2005,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
J. Burke,
A. Eisen,
M. Kohli,
2016,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
A. Alencar,
A. Zelenetz,
I. Flinn,
2022,
Blood.
R. Walgren,
S. Karve,
K. Davis,
2014,
PloS one.
M. Salama,
S. Verstovsek,
R. Mesa,
2017,
Leukemia research.
E. Van Cutsem,
Jiangang Liu,
R. Walgren,
2021,
The Lancet. Oncology.
R. Walgren,
G. Pohl,
G. Price,
2011
.
R. Walgren,
T. Walle,
1999,
The Journal of pharmacy and pharmacology.
R. Walgren,
J. Manro,
V. Wacheck,
2017,
Investigational New Drugs.
J. Lacy,
M. Shah,
C. Fuchs,
2018
.
T. Powles,
H. Nishiyama,
H. Harputluoglu,
2019,
The Lancet. Oncology.
T. Powles,
H. Nishiyama,
C. Sternberg,
2017
.
R. Walgren,
T. Walle,
U. Walle,
1998,
Biochemical pharmacology.
J. Vose,
R. Walgren,
C. Tam,
2022,
Blood.
R. Walgren,
Liandong Ma,
Baohui Zhao,
2011
.
C. Allerston,
B. Brandhuber,
T. Morales,
2023,
Blood.
R. M. Beckstead,
R. Walgren,
P. Privitera,
2003,
Cellular and Molecular Neurobiology.
E. Van Cutsem,
J. Tabernero,
K. Muro,
2021,
Current medical research and opinion.
J. Prchal,
R. Walgren,
2012
.
R. Walgren,
J. Pagel,
T. Sugihara,
2023,
Leukemia & lymphoma.
R. Walgren,
Wayne D. Blosser,
Liandong Ma,
2010
.
L. Arenillas,
B. Bellosillo,
R. Walgren,
2010
.
R. Walgren,
J. Manro,
J. Wijsman,
2013,
Clinical Cancer Research.
A. Alencar,
A. Zelenetz,
I. Flinn,
2023,
Journal of Clinical Oncology.
S. Verstovsek,
R. Mesa,
J. Prchal,
2011
.
Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F
P. Iversen,
R. Walgren,
B. Zhao,
2013,
Blood Cancer Journal.